The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases

BMB Reports

Volumn 46, Issue 10, 2013, Pages 479-483

  Lee, Youngkyun ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Bone metabolism; IL 17; Periodontitis; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 17;

ANIMAL; ARTICLE; BONE; HUMAN; INFLAMMATION; METABOLISM;

ANIMALS; BONE AND BONES; HUMANS; INFLAMMATION; INTERLEUKIN-17;

EID: 84886795071     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.10.141     Document Type: Article

References (48)

1. Moseley, T. A., Haudenschild, D. R., Rose, L. and Reddi, A. H. (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14, 155-174.
2. Rouvier, E., Luciani, M. F., Mattei, M. G., Denizot, F. and Golstein, P. (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150, 5445-5456.
3. Witowski, J., Ksiazek, K. and Jorres, A. (2004) Interleukin-17: a mediator of inflammatory responses. Cell Mol. Life Sci. 61, 567-579.
4. Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K. (2009) IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517.
5. Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A. M., Painter, S. L., Comeau, M. R., Cohen, J. I. and Spriggs, M. K. (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3, 811-821.
6. Kuestner, R. E., Taft, D. W., Haran, A., Brandt, C. S., Brender, T., Lum, K., Harder, B., Okada, S., Ostrander, C. D., Kreindler, J. L., Aujla, S. J., Reardon, B., Moore, M., Shea, P., Schreckhise, R., Bukowski, T. R., Presnell, S., Guerra-Lewis, P., Parrish-Novak, J., Ellsworth, J. L., Jaspers, S., Lewis, K. E., Appleby, M., Kolls, J. K., Rixon, M., West, J. W., Gao, Z. and Levin, S. D. (2007) Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179,5462-5473.
7. Toy, D., Kugler, D., Wolfson, M., Vanden Bos, T., Gurgel, J., Derry, J., Tocker, J. and Peschon, J. (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177, 36-39.
8. Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., Osterreicher, C. H., Stickel, F., Ley, K., Brenner, D. A. and Kisseleva, T. (2012) Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765-776.
9. Gu, Y., Hu, X., Liu, C., Qv, X. and Xu, C. (2008) Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia. Br. J. Haematol. 142, 109-114.
10. Kawanokuchi, J., Shimizu, K., Nitta, A., Yamada, K., Mizuno, T., Takeuchi, H. and Suzumura, A. (2008) Production and functions of IL-17 in microglia. J. Neuroimmunol. 194, 54-61.
11. Beklen, A., Ainola, M., Hukkanen, M., Gurgan, C., Sorsa, T. and Konttinen, Y. T. (2007) MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J. Dent. Res. 86, 347-351.
12. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F. and Pelletier, J. P. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160, 3513-3521.
13. Mahanonda, R., Jitprasertwong, P., Sa-Ard-Iam, N., Rerkyen, P., Charatkulangkun, O., Jansisyanont, P., Nisapakultorn, K., Yongvanichit, K. and Pichyangkul, S. (2008) Effects of IL-17 on human gingival fibroblasts. J. Dent. Res. 87, 267-272.
14. Shahrara, S., Pickens, S. R., Mandelin, A. M. 2nd, Karpus, W. J., Huang, Q., Kolls, J. K. and Pope, R. M. (2010) IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J. Immunol. 184, 4479-4487.
15. Barin, J. G., Baldeviano, G. C., Talor, M. V., Wu, L., Ong, S., Quader, F., Chen, P., Zheng, D., Caturegli, P., Rose, N. R. and Cihakova, D. (2012) Macrophages participate in IL-17-mediated inflammation. Eur. J. Immunol. 42, 726-736.
16. Hosokawa, Y., Hosokawa, I., Ozaki, K., Nakanishi, T., Nakae, H. and Matsuo, T. (2009) Catechins inhibit CCL20 production in IL-17A-stimulated human gingival fibroblasts. Cell. Physiol. Biochem. 24, 391-396.
17. Zhang, F., Tanaka, H., Kawato, T., Kitami, S., Nakai, K., Motohashi, M., Suzuki, N., Wang, C. L., Ochiai, K., Isokawa, K. and Maeno, M. (2011) Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Biochimie 93, 296-305.
18. Zhang, F., Koyama, Y., Sanuki, R., Mitsui, N., Suzuki, N., Kimura, A., Nakajima, A., Shimizu, N. and Maeno, M. (2010) IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells. Arch. Oral Biol. 55, 679-688.
19. Van Bezooijen, R. L., Papapoulos, S. E. and Lowik, C. W. (2001) Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling? Bone 28, 378-386.
20. Trajkovic, V., Stosic-Grujicic, S., Samardzic, T., Markovic, M., Miljkovic, D., Ramic, Z. and Mostarica Stojkovic, M. (2001) Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol. 119, 183-191.
21. Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., Martin, T. J. and Suda, T. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103, 1345-1352.
22. Van bezooijen, R. L., Farih-Sips, H. C., Papapoulos, S. E. and Lowik, C. W. (1999) Interleukin-17: A new bone acting cytokine in vitro. J. Bone Miner. Res. 14, 1513-1521.
23. Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., Cua, D. J. and Takayanagi, H. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673-2682.
24. Yago, T., Nanke, Y., Ichikawa, N., Kobashigawa, T., Mogi, M., Kamatani, N. and Kotake, S. (2009) IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J. Cell Biochem. 108, 947-955.
25. Kitami, S., Tanaka, H., Kawato, T., Tanabe, N., Katono-Tani, T., Zhang, F., Suzuki, N., Yonehara, Y. and Maeno, M. (2010) IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie 92, 398-404.
26. Balani, D., Aeberli, D., Hofstetter, W. and Seitz, M. (2013) Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. Arthritis Rheum. 65, 436-446.
27. Huang, W., La Russa, V., Alzoubi, A. and Schwarzenberger, P. (2006) Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells. Stem Cells (Dayton, Ohio) 24, 1512-1518.
28. Huang, H., Kim, H. J., Chang, E. J., Lee, Z. H., Hwang, S. J., Kim, H. M., Lee, Y. and Kim, H. H. (2009) IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell. Death. Differ. 16, 1332-1343.
29. Nam, D., Mau, E., Wang, Y., Wright, D., Silkstone, D., Whetstone, H., Whyne, C. and Alman, B. (2012) T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PloS One 7, e40044.
30. Kocic, J., Santibanez, J. F., Krstic, A., Mojsilovic, S., Dordevic, I. O., Trivanovic, D., Ilic, V. and Bugarski, D. (2012) Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activatingERK1,2. Biochim. Biophys. Acta. 1823, 838-849.
31. Ahmed, M. and Gaffen, S. L. (2010) IL-17 in obesity and adipogenesis. Cytokine. Growth Factor Rev. 21, 449-453.
32. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., van den Bersselaar, L., Coenen-de Roo, C. J., Joosten, L. A. and van den Berg, W. B. (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50, 650-659.
33. Koenders, M. I., Lubberts, E., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M. M., Di Padova, F. E., Boots, A. M., Gram, H., Joosten, L. A. and van den Berg, W. B. (2005) Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol. 167, 141-149.
34. Koenders, M. I., Kolls, J. K., Oppers-Walgreen, B., van den Bersselaar, L., Joosten, L. A., Schurr, J. R., Schwarzenberger, P., van den Berg, W. B. and Lubberts, E. (2005) Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239-3247.
35. Genovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P. and Sloan-Lancaster, J. (2010) LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum. 62, 929-939.
36. Koenders, M. I., Marijnissen, R. J., Joosten, L. A., Abdollahi-Roodsaz, S., Di Padova, F. E., van de Loo, F. A., Dulos, J., van den Berg, W. B. and Boots, A. M. (2012) T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization. Arthritis Rheum. 64, 1762-1770.
37. Zwerina, K., Koenders, M., Hueber, A., Marijnissen, R. J., Baum, W., Heiland, G. R., Zaiss, M., McLnnes, I., Joosten, L., van den Berg, W., Zwerina, J. and Schett, G. (2012) Anti IL-17A therapy inhibits bone loss in TNF-alpha-mediated murine arthritis by modulation of the T-cell balance. Eur. J. Immunol. 42, 413-423.
38. Chao, C. C., Chen, S. J., Adamopoulos, I. E., Davis, N., Hong, K., Vu, A., Kwan, S., Fayadat-Dilman, L., Asio, A. and Bowman, E. P. (2011) Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis. Autoimmunity 44, 243-252.
39. Lubberts, E., van den Bersselaar, L., Oppers-Walgreen, B., Schwarzenberger, P., Coenen-de Roo, C. J., Kolls, J. K., Joosten, L. A. and van den Berg, W. B. (2003) IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/ osteoprotegerin balance. J. Immunol. 170, 2655-2662.
40. Kikuta, J., Wada, Y., Kowada, T., Wang, Z., Sun-Wada, G. H., Nishiyama, I., Mizukami, S., Maiya, N., Yasuda, H., Kumanogoh, A., Kikuchi, K., Germain, R. N. and Ishii, M. (2013) Dynamic visualization of RANKL and Th17-mediated osteoclast function. J. Clin. Invest. 123, 866-873.
41. Bartold, P. M., Cantley, M. D. and Haynes, D. R. (2010) Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000 53, 55-69.
42. Oda, T., Yoshie, H. and Yamazaki, K. (2003) Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol. Immunol. 18, 30-36.
43. Takahashi, K., Azuma, T., Motohira, H., Kinane, D. F. and Kitetsu, S. (2005) The potential role of interleukin-17 in the immunopathology of periodontal disease. J. Clin. Periodentol. 32, 369-374.
44. Vernal, R., Dutzan, N., Chaparro, A., Puente, J., Antonieta Valenzuela, M. and Gamonal, J. (2005) Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J. Clin. Periodontol. 32, 383-389.
45. Yu, J. J., Ruddy, M. J., Wong, G. C., Sfintescu, C., Baker, P. J., Smith, J. B., Evans, R. T. and Gaffen, S. L. (2007) An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109, 3794-3802.
46. Schenkein, H. A., Koertge, T. E., Brooks, C. N., Sabatini, R., Purkall, D. E. and Tew, J. G. (2010) IL-17 in sera from patients with aggressive periodontitis. J. Dent. Res 89, 943-947.
47. Duarte, P. M., da Rocha, M., Sampaio, E., Mestnik, M. J., Feres, M., Figueiredo, L. C., Bastos, M. F. and Faveri, M. (2010) Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J. Periodontol. 81, 1056-1063.
48. Adibrad, M., Deyhimi, P., Ganjalikhani Hakemi, M., Behfarnia, P., Shahabuei, M. and Rafiee, L. (2012) Signs of the presence of Th17 cells in chronic periodontal disease. J. Periodontal Res. 47, 525-531.